Skip to contentS
Skye Bioscience, Inc.
S
SKYESkye Bioscience, Inc. Released Nov 14, 2017, after the close
10-Q filed Nov 14, 2017, 45 days after period end · 0001640334-17-002417
Q3 2017 · 10-Q
Revenue—
Net Income-$480.13K-$480.13KN/M vs Q3 2016N/M vs Q2 2017 No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skye Bioscience, Inc. · CIK 1516551 · Engraved from SEC EDGAR
EPS Diluted-$0.02-$0.02N/M vs Q3 2016N/M vs Q2 2017 Operating Income-$761,630N/M Operating Cash Flowderived-$99,953N/M Filing lag
ended Sep 30, 2017 · filed Nov 14, 2017 · 45 d after period end